Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes

Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes

<p><strong>Background</strong></p> Relapse infections resulting from the activation hypnozoites produced by Plasmodium vivax and Plasmodium ovale represent an important obstacle to the successful control of these species. A single licensed drug, primaquine is available to eli...

Full description

Bibliographic Details
Main Authors:	Maneerattanasak, S, Gosi, P, Krudsood, S, Chimma, P, Tongshoob, J, Mahakunkijcharoen, Y, Sukasem, C, Imwong, M, Snounou, G, Khusmith, S
Format:	Journal article
Language:	English
Published:	BioMed Central 2017

Similar Items

Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes
by: Sarunya Maneerattanasak, et al.
Published: (2017-05-01)

The genetic diversity of Plasmodium vivax populations.
by: Cui, L, et al.
Published: (2003)

High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
by: Krudsood, S, et al.
Published: (2008)

Microsatellite genotyping of Plasmodium vivax infections and their relapses in pregnant and non-pregnant patients on the Thai-Myanmar border.
by: Thanapongpichat, S, et al.
Published: (2013)

Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites.
by: Imwong, M, et al.
Published: (2007)

Polymorphism patterns in Duffy-binding protein among Thai <it>Plasmodium vivax </it>isolates
by: Schaecher Kurt E, et al.
Published: (2008-06-01)

The first Plasmodium vivax relapses of life are usually genetically homologous.
by: Imwong, M, et al.
Published: (2012)

Geographical variation in Plasmodium vivax relapse
by: Battle, K, et al.
Published: (2014)

Geographical variation in Plasmodium vivax relapse.
by: Battle, K, et al.
Published: (2014)

Malaric relapses due to Plasmodium Vivax Reinfección engógena por Plasmodium vivax
by: Cecilia Giraldo, et al.
Published: (1991-01-01)

Management of relapsing Plasmodium vivax malaria
by: Chu, C, et al.
Published: (2016)

Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine
by: Chamnanphon M, et al.
Published: (2020-01-01)

Molecular characterization of dihydrofolate reductase in relation to antifolate resistance in Plasmodium vivax.
by: Leartsakulpanich, U, et al.
Published: (2002)

Genetic Spatiotemporal Anatomy of Plasmodium vivax Malaria Episodes in Greece, 2009–2013
by: Gregory Spanakos, et al.
Published: (2018-03-01)

Population heterogeneity in Plasmodium vivax relapse risk.
by: Eva Stadler, et al.
Published: (2022-12-01)

Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria
by: Lacerda, MVG, et al.
Published: (2019)

Plasmodium vivax Malaria Relapses after Primaquine Prophylaxis
by: Pavani Reddy, et al.
Published: (2006-11-01)

Chloroquine sensitivity of Plasmodium vivax in Thailand.
by: Looareesuwan, S, et al.
Published: (1999)

Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1.
by: Imwong, M, et al.
Published: (2005)

Tafenoquine for the prevention of Plasmodium vivax malaria relapse
by: Watson, JA, et al.
Published: (2021)

Determinants of relapse periodicity in Plasmodium vivax malaria.
by: White, N
Published: (2011)

Primaquine as anti-relapse therapy for Plasmodium vivax
by: Baird, J
Published: (1998)

Hypnozoite depletion in successive Plasmodium vivax relapses.
by: Rintis Noviyanti, et al.
Published: (2022-07-01)

Tafenoquine for the prevention of Plasmodium vivax malaria relapse
by: James A Watson, et al.
Published: (2021-05-01)

Determinants of relapse periodicity in <it>Plasmodium vivax </it>malaria
by: White Nicholas J
Published: (2011-10-01)

Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates.
by: Imwong, M, et al.
Published: (2001)

Microsatellite characterization of <it>Plasmodium vivax</it> in pregnant women on the Thai–Myanmar border
by: Thanapongpichat Supinya, et al.
Published: (2012-11-01)

Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata.
by: Jung-Ryong Kim, et al.
Published: (2012-01-01)

Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata.
by: Kim, JR, et al.
Published: (2012)

Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand.
by: Imwong, M, et al.
Published: (2005)

Methotrexate is highly potent against pyrimethamine-resistant Plasmodium vivax.
by: Imwong, M, et al.
Published: (2011)

Practical PCR genotyping protocols for <it>Plasmodium vivax </it>using <it>Pvcs </it>and <it>Pvmsp1</it>
by: Looareesuwan Sornchai, et al.
Published: (2005-04-01)

Plasmodium simium: a Brazilian focus of anthropozoonotic vivax malaria?
by: Matthew J Grigg, et al.
Published: (2017-10-01)

Probabilistic model of Plasmodium vivax relapse for improved estimation of treatment efficacy using time-to-recurrence dynamics
by: Watson, J, et al.
Published: (2018)

Acquired haemophilia A in early pregnancy associated with Plasmodium vivax malaria and hyperthyroidism.
by: Mcgready, R, et al.
Published: (2007)

Plasmodium vivax: polymerase chain reaction amplification artifacts limit the suitability of pvgam1 as a genetic marker.
by: Imwong, M, et al.
Published: (2001)

Severe orthostatic hypotension in otherwise uncomplicated Plasmodium vivax infection.
by: Sivakorn, C, et al.
Published: (2021)

The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand.
by: Snounou, G, et al.
Published: (2004)

Drug resistance of Plasmodium falciparum and Plasmodium vivax isolates in Indonesia
by: Rahmasari, FV, et al.
Published: (2022)

TRIANGULAR TEST DESIGN TO EVALUATE TINIDAZOLE IN THE PREVENTION OF PLASMODIUM VIVAX RELAPSE
by: Macareo, L, et al.
Published: (2009)